The cases are reported of two infants with pneumococcal meningitis in whom initial antibiotic treatment was ineffective despite the organisms being sensitive to the drugs used. A clinical and radiological diagnosis of meningoencephalitis was made. A rapid improvement followed the addition of rifampicin treatnent.
Pneumococcal meningitis is a life threatening disease with an incidence of 1-3 in 100 000.1 Mortality may be as high as 30%. A (fig 2) . Cefotaxime was restarted with the addition of intravenous rifampicin (20 mg/kg/day in two divided doses). He made a rapid recovery with his temperature falling to normal within 36 hours and a complete cessation of his fits (fig 1) . He was maintained on intravenous antibiotics for a further three weeks before taking rifampicin and co-trimoxazole by mouth for two weeks.
On discharge he had marked left hemiparesis and a mild right sided weakness. Repeat computed tomography showed generalised cerebral atrophy with resolution of the appearances of cerebritis.
Discussion
These cases show a clear clinical improvement in severe pneumococcal meningoencephalitis with rifampicin treatment. This followed the failure of a prolonged course of treatment with antibiotics to which the pneumococcal isolates were sensitive. A previous report of pneumococcal meningitis in the presence of a ventriculoperitoneal shunt describes similar findings.7 Treatment with benzylpenicillin and cefotaxime for nine days was ineffective, but after the addition of rifampicin the child made a rapid recovery without removal of the shunt.
We believe our patients are not typical in that the degree of cerebritis was much greater than the characteristically mild disorder seen in many cases of bacterial meningitis.' This fact may partially explain the dramatic response achieved with rifampicin because of the high cerebrospinal fluid levels and excellent tissue penetration it exhibits, even in the absence of marked meningeal inflammation. Another possible explanation for the efficacy of rifampicin may have been the persistence of bacteria within host cells which provide an effective barrier to 1 lactam antibiotic treatment. In this situation the intracellular penetration of rifampicin may have allowed it to be effective in eradicating infection when treatment with antibiotics with poor cell penetration had failed. Lastly, bacterial exposure to 13 lactam antibiotics may result in the formation of cell wall deficient bacteria or wall deficient bacteria and may have eradicated cell wall deficient pneumococci in these two patients.
We conclude that in pneumococcal meningitis when i lactam antibiotics are ineffective, the diagnosis of meningoencephalitis should be considered. In this situation rifampicin may be a useful addition to the treatment.
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